The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

Tue, 15th Apr 2014 15:08

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend reinvestment.

Details are as follows.

Sir Andrew Witty

Acquisition of 2,101 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 2,101 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S Dingemans

Acquisition of 924 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 924 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Dr M M Slaoui

Acquisition of 791 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 791 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr S M Bicknell

Acquisition of 210 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 210 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mrs D P Connelly

Acquisition of 153 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 153 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr R G Connor

Acquisition of 236 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 236 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S A Hussain

Acquisition of 119 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 119 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

 

Acquisition of 191 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 191 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr D S Redfern

Acquisition of 449 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 449 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms C Thomas 

Acquisition of 338 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 338 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr P C Thomson

Acquisition of 69 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 69 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr D E Troy

Acquisition of 350 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 350 ADSs under the matching element of the Plan (Company contribution).

 

 

Dr P J T Vallance

Acquisition of 986 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 986 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms E Walmsley

Acquisition of 544 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 544 Ordinary Shares under the matching element of the Plan (Company contribution).

 



Shares in the global healthcare company were trading at 1,549.00 pence up 0.4% Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut ...

Today 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpa...

25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related...

24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.